Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bari
Clinical trial register · Italy

Clinical Trials in Bari, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 98 Roma 43 Naples 40 Rome 40 Rozzano 27
Narrow the registerReset
Recruitment status
Phase
Site location
Milan98 Roma43 Naples40 Rome40 Rozzano27
All 66 locations
Target enrolment
to

Trials with a site in Bari

17 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Meldola, Rozzano, Catselfranco Veneto, Florence, Bari, Bologna, Milan, Perugia
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bologna, Aviano, Rome, Milan, Rozzano, Candiolo, Bari, Brescia
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Bari, Aviano, Udine, Milan, Naples, Perugia, Catania, Cuneo
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Bari, Meldola, Rome, Milan, Orbassano, Florence, Arezzo, Bologna
2022-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Rome, Milan, Monza, Rozzano, Bari, Catania, Naples, Padova
2021-06-18
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Bari, Rome, Milan, Florence, Modena, Naples, Province of Macerata
2020-05-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Rome, Padova, Bari, Catania, Roma
2020-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Verona, Arezzo, Bari, Bologna, Milan, Modena, Padova, Pavia
2020-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bari

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Bari that also match the filters currently applied.

How many clinical trials are recruiting in Bari?

5 of the 17 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bari), 17 studies
PhaseStudiesRecruitingShare
Phase 316494.1%
Phase 2115.9%

Most active sponsors

Lead sponsors with the most studies (Bari)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC175
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.